Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Amh Biotech LLC is handling 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This single action is assigned to 1 distinct examiner and 1 distinct art unit. The portfolio's current activity is focused on a single administrative channel, which simplifies the coordination of the current prosecution effort. This concentration allows for a highly targeted strategy that is tailored to the specific technical standards of the assigned art unit within the Biotechnology & Pharmaceuticals field.
HIBSHMAN, SARAH GRACE is the busiest examiner, overseeing 1 pending office action. As the only examiner currently reviewing the company's applications, HIBSHMAN, SARAH GRACE's specific approach is the primary factor for the applicant to consider. Practitioners should evaluate the examiner's history to anticipate the likely direction of the pending case. The streamlined prosecution environment, involving only 1 art unit and 1 examiner, allows for a focused and efficient response to the patent office's requirements, ensuring that all resources are directed toward a single point of contact.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HIBSHMAN, SARAH GRACE | 1 | 38.9% | +40.0% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19237691 | FLAVONOID-CONTAINING COMPOSITIONS AND TREATMENT OF VIRAL DISEASES WITH SAME | HIBSHMAN, SARAH GRACE | 43d overdue |
| Art Unit | Apps |
|---|---|
| 1623 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19237691 | FLAVONOID-CONTAINING COMPOSITIONS AND TREATMENT OF VIRAL DISEASES WITH SAME | HIBSHMAN, SARAH GRACE | 1623 | §103 | Non-Final OA | 43d overdue | Pending | Jun 13, 2025 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial